Aster DM Health.

Who are the top shareholders of the Aster DM Health.?

The top shareholders of Aster DM Health include promoters holding the majority, with Union Investments Private Limited owning 36.06%. Institutional investors, including mutual funds and foreign institutional investors, hold 23.46% and 23.62%, respectively, while individual shareholders collectively own 4.12%.

The top shareholders of Aster DM Health include a mix of promoters, institutional investors, and individual shareholders. The majority of the shares are held by promoters, with Union Investments Private Limited being the largest individual promoter, holding 36.06%. <BR><BR>In terms of institutional holdings, mutual funds account for 23.46% through 23 different schemes, while foreign institutional investors (FIIs) hold 23.62% of the shares. The highest public shareholder is Rimco (Mauritius) Limited, which owns 8.27%. Individual investors collectively hold 4.12% of the company’s shares. <BR><BR>Overall, the shareholding structure reflects a strong presence of promoter and institutional investors in Aster DM Health.

Who are in the management team of Aster DM Health.?

As of March 2022, the management team of Aster DM Health includes Chairman Mandayapurath Azad Moopen, Executive Director Alisha Moopen, and several non-executive and independent directors, totaling 12 members, including the Company Secretary. This diverse team oversees the company's governance and strategic direction.

As of March 2022, the management team of Aster DM Health includes the following individuals:<BR><BR>1. Mandayapurath Azad Moopen - Chairman & Executive Director<BR>2. Alisha Moopen - Executive Director / Deputy Managing Director<BR>3. Thadathil Wilson - Non Executive Director<BR>4. Anoop Moopen - Non Executive Director<BR>5. Shamsudheen Bin Mohideen Mammu Haji - Non Executive Director<BR>6. Daniel Robert Mintz - Non Executive Director<BR>7. C J George - Independent Non Executive Director<BR>8. James Mathew - Independent Non Executive Director<BR>9. Wayne Earl Keathley - Independent Non Executive Director<BR>10. Mr. Emmanuel David Gootam - Independent Non Executive Director<BR>11. DEEPTI PURANA HOUSDURGAMVIJAYA - Independent Non Executive Director<BR>12. Hemish Purushottam - Company Secretary & Compliance Officer<BR><BR>This team comprises a mix of executive, non-executive, and independent directors, contributing to the governance and strategic direction of the company.

Has Aster DM Health. declared dividend?

Aster DM Healthcare Ltd has declared a 40% dividend, amounting to ₹4 per share, with an ex-date of February 10, 2025. The company has demonstrated strong financial performance, achieving total returns of 577.43% over the past five years.

Aster DM Healthcare Ltd has declared a 40% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 40%<BR>- Amount per share: 4<BR>- Ex-date: 10 Feb 25<BR><BR>Dividend Yield: 1.03%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the company achieved a price return of 18.2%, a dividend return of 0.82%, resulting in a total return of 19.02%.<BR><BR>Over the past year, Aster DM Healthcare Ltd experienced a price return of 61.98%, a dividend return of 1.67%, leading to a total return of 63.65%.<BR><BR>In the 2-year period, the company saw a price return of 114.93%, a dividend return of 43.18%, culminating in a total return of 158.11%.<BR><BR>For the last 3 years, the price return was 207.85%, with a dividend return of 71.70%, resulting in a total return of 279.55%.<BR><BR>In the 4-year period, Aster DM Healthcare Ltd recorded a price return of 285.97%, a dividend return of 79.64%, achieving a total return of 365.61%.<BR><BR>Over the last 5 years, the company experienced a price return of 475.12%, a dividend return of 102.31%, resulting in a total return of 577.43%.<BR><BR>Overall, Aster DM Healthcare Ltd has not only declared a significant dividend but has also shown impressive total returns across multiple periods, indicating strong financial performance and shareholder value enhancement.

Who are the peers of the Aster DM Health.?

Aster DM Health's peers include Max Healthcare, Apollo Hospitals, Fortis Health, Narayana Hrudaya, Global Health, and others. Aster DM Health has average management risk, below average growth, and below average capital structure, with a 1-year return of 55.28%.

Peers: The peers of Aster DM Health are Max Healthcare, Apollo Hospitals, Fortis Health., Narayana Hrudaya, Global Health, Krishna Institu., Rainbow Child., Dr Agarwal's Hea, Jupiter Life Lin, and Health.Global.<BR><BR>Quality Snapshot: Excellent management risk is observed at Max Healthcare, Apollo Hospitals, Narayana Hrudaya, Global Health, Krishna Institu., Rainbow Child., Dr Agarwal's Hea, Jupiter Life Lin, and the rest. Average management risk is found at Fortis Health. and Aster DM Health., while below average management risk is noted at Health.Global. Excellent growth is seen at Max Healthcare and Apollo Hospitals, while good growth is observed at Fortis Health., Narayana Hrudaya, Dr Agarwal's Hea, and the rest. Below average growth is noted at Aster DM Health., Krishna Institu., Rainbow Child., and the rest. Excellent capital structure is seen at Max Healthcare, Global Health, Krishna Institu., and Jupiter Life Lin, while average capital structure is found at Apollo Hospitals and good capital structure at Fortis Health., Narayana Hrudaya, Dr Agarwal's Hea, Rainbow Child., and the rest. Below average capital structure is noted at Aster DM Health. and Health.Global.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Krishna Institu. at 85.63%, while the peer with the lowest is Dr Agarwal's Hea with no available data. Aster DM Health. has a 1-year return of 55.28%, which is lower than Krishna Institu. but higher than Dr Agarwal's Hea. Additionally, Rainbow Child. has a negative six-month return of -14.69%.

What does Aster DM Health. do?

Aster DM Healthcare Ltd is a prominent healthcare provider in the GCC and India, operating hospitals and classified as a large-cap company. As of March 2025, it reported net sales of ₹10,003 Cr and a net profit of ₹790 Cr, with a market cap of ₹31,072 Cr.

Overview:<BR>Aster DM Healthcare Ltd is a leading healthcare provider in the GCC and India, operating within the hospital industry and classified as a large-cap company.<BR><BR>History:<BR>Aster DM Healthcare Ltd was originally incorporated as 'Aster DM Healthcare Private Limited' on January 18, 2008, and was converted into a public limited company on November 29, 2013. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 10,003 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 790 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: INR 31,072 Cr (Large Cap)<BR><BR>Key Metrics:<BR>- P/E: 16.00<BR>- Industry P/E: 59<BR>- Dividend Yield: 0.98%<BR>- Debt-Equity: 0.19<BR>- Return on Equity: 58.18%<BR>- Price to Book: 9.06<BR><BR>Contact Details:<BR>Address: IX/475L Aster Medcity, Kuttisahib Road Cheranalloore Kochi Kerala : 682027<BR>Tel: 91-0484-6699228<BR>Email: investors@asterdmhealthcare.com<BR>Website: http://www.asterdmhealthcare.com

How big is Aster DM Health.?

As of 24th July, Aster DM Healthcare Ltd has a market capitalization of 31,276.00 Cr, with recent net sales of 4,138.46 Cr and a net profit of 5,377.83 Cr.

As of 24th July, Aster DM Healthcare Ltd has a market capitalization of 31,276.00 Cr and is classified as a Large Cap company.<BR><BR>In the latest four quarters, Aster DM Healthcare reported Net Sales of 4,138.46 Cr and a Net Profit of 5,377.83 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 4,559.79 Cr and Total Assets totaling 17,982.66 Cr.

How has been the historical performance of Aster DM Health.?

Aster DM Health's historical performance shows strong growth in net sales and profitability metrics, with net sales rising from 2,994.05 Cr in Mar'23 to 4,138.46 Cr in Mar'25, while profit after tax increased from 170.81 Cr to 355.60 Cr. However, total operating income peaked in Mar'22 and has since declined, alongside a significant drop in total assets and liabilities.

Answer:<BR>The historical performance of Aster DM Health shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Aster DM Health's net sales have increased from 2,994.05 Cr in Mar'23 to 4,138.46 Cr in Mar'25, indicating a strong upward trend. However, total operating income peaked at 10,253.28 Cr in Mar'22 before declining to 4,138.46 Cr in Mar'25. The total expenditure, excluding depreciation, rose from 2,544.97 Cr in Mar'23 to 3,373.93 Cr in Mar'25, reflecting increased operational costs. Operating profit (PBDIT) also showed improvement, rising from 449.08 Cr in Mar'23 to 764.53 Cr in Mar'25, while profit before tax increased from 206.68 Cr in Mar'23 to 489.97 Cr in Mar'25. Profit after tax followed a similar trend, growing from 170.81 Cr in Mar'23 to 355.60 Cr in Mar'25. The earnings per share (EPS) surged dramatically from 8.51 in Mar'23 to 107.66 in Mar'25. On the balance sheet, total liabilities decreased significantly from 17,982.66 Cr in Mar'24 to 6,600.17 Cr in Mar'25, while total assets also declined from 17,982.66 Cr to 6,600.17 Cr in the same period. Cash flow from operating activities improved from 157.00 Cr in Mar'24 to 425.00 Cr in Mar'25, while cash flow from investing activities saw a substantial increase to -6,015.00 Cr in Mar'25. Overall, Aster DM Health has experienced a complex financial journey with notable improvements in profitability metrics despite fluctuations in total income and assets.

Is Aster DM Health. technically bullish or bearish?

As of November 19, 2025, Aster DM Health's trend is mildly bullish, supported by daily moving averages and KST indicators, despite some caution from the weekly MACD and recent price declines.

As of 19 November 2025, the technical trend for Aster DM Health has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the daily moving averages indicating a positive trend. However, the weekly MACD is mildly bearish, which introduces some caution. The Bollinger Bands on both weekly and monthly time frames are mildly bullish, suggesting potential upward movement. The KST is bullish on both weekly and monthly charts, reinforcing the positive outlook. Despite recent price declines, the stock has shown strong returns over longer periods, outperforming the Sensex significantly in the 1Y, 3Y, and 5Y periods. Overall, while there are mixed signals, the prevailing trend remains mildly bullish.

Is Aster DM Health. overvalued or undervalued?

As of December 2, 2025, Aster DM Health is considered overvalued with a PE ratio of 92.00 and high valuation metrics compared to peers, despite a strong year-to-date return of 29.47%.

As of 2 December 2025, the valuation grade for Aster DM Health has moved from very expensive to expensive, indicating a slight improvement in perceived value but still reflecting high valuation metrics. The company is currently considered overvalued. Key ratios include a PE ratio of 92.00, an EV to EBITDA of 42.07, and a Price to Book Value of 7.60, all of which are significantly higher than industry norms.<BR><BR>In comparison to peers, Aster DM Health's PE ratio is notably higher than Apollo Hospitals at 62.27 and Narayana Hrudaya at 45.93, both of which are categorized as expensive. Additionally, Aster's PEG ratio stands at 0.00, suggesting no growth expectations priced into the stock, which is concerning. Despite a strong year-to-date return of 29.47% compared to the Sensex's 8.96%, the high valuation metrics indicate that Aster DM Health may not be a prudent investment at its current price of 665.10.

When is the next results date for Aster DM Healthcare Ltd?

The next results date for Aster DM Healthcare Ltd is January 30, 2026.

The next results date for Aster DM Healthcare Ltd is scheduled for January 30, 2026.

Are Aster DM Healthcare Ltd latest results good or bad?

Aster DM Healthcare Ltd's latest Q3 FY26 results are concerning, with a 52.32% drop in net profit quarter-on-quarter and a decline in operating margins, indicating significant operational challenges despite a year-on-year sales increase. Overall, the financial performance can be characterized as negative.

Aster DM Healthcare Ltd's latest results for Q3 FY26 indicate a challenging financial performance. The consolidated net profit fell sharply by 52.32% quarter-on-quarter to ₹52.45 crores, and there was a 7.64% decline year-on-year. This significant drop in profit is concerning, especially following a strong profit growth of 28.62% in the previous quarter.<BR><BR>Net sales also experienced a slight decline of 0.96% from the previous quarter, totaling ₹1,185.76 crores, although there was a year-on-year increase of 12.95%. The operating margin, excluding other income, decreased to 17.82%, down 305 basis points from the previous quarter, while the PAT margin dropped to 4.95%, reflecting a 518 basis point decline.<BR><BR>The results highlight a combination of margin compression, elevated tax rates, and stagnant revenue growth, which raises questions about the company's operational efficiency and competitive positioning in the healthcare sector. Overall, these results can be characterized as negative, indicating serious operational challenges that the company needs to address moving forward.

Should I buy, sell or hold Aster DM Healthcare Ltd?

Why is Aster DM Healthcare Ltd falling/rising?

As of 07-Apr, Aster DM Healthcare Ltd's stock price is declining, currently at 654.25, reflecting a decrease of 2.38%. This drop is driven by reduced investor participation, poor financial performance, high debt levels, and pledged shares, contributing to negative market sentiment.

As of 07-Apr, Aster DM Healthcare Ltd's stock price is falling, currently at 654.25, which reflects a decrease of 15.95 or 2.38%. This decline is evident in the stock's performance today, where it underperformed its sector by 3.24%. The stock touched an intraday low of Rs 653.95, indicating a significant drop of 2.42% during the trading session.<BR><BR>Several factors contribute to this downward movement. Firstly, there is a notable decrease in investor participation, with delivery volume dropping by 69.82% compared to the 5-day average. This lack of interest from investors can lead to reduced demand for the stock, further driving down its price. Additionally, while the stock is currently trading above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day moving averages, suggesting a short-term bearish trend.<BR><BR>Financially, Aster DM Healthcare Ltd faces challenges, including a high Debt to EBITDA ratio of 2.49 times, indicating a low ability to service its debt. Furthermore, the company has experienced poor long-term growth, with net sales declining at an annual rate of 12.24% over the last five years. The negative results reported for the nine months ending December, including a significant drop in profit after tax (PAT) by 85.86%, and the lowest earnings per share (EPS) at Rs 1.01, also contribute to the stock's negative sentiment.<BR><BR>Moreover, the fact that 40.66% of promoter shares are pledged adds to the downward pressure, particularly in a falling market. This situation can create additional concerns for investors regarding the stability and future performance of the company.<BR><BR>In summary, the combination of declining investor participation, poor financial performance, high debt levels, and pledged shares has led to the current decline in Aster DM Healthcare Ltd's stock price.

Why is Aster DM Healthcare Ltd falling/rising?

As of 08-Apr, Aster DM Healthcare Ltd's stock price is rising to 667.00, driven by positive market sentiment and strong year-to-date performance. However, challenges such as a high Debt to EBITDA ratio and declining net sales growth may pose risks to its future stability.

As of 08-Apr, Aster DM Healthcare Ltd's stock price is rising, currently at 667.00, with a change of 11.25 (1.72%) upward. This increase can be attributed to several factors. Firstly, the stock opened with a significant gain of 4.61% today and reached an intraday high of Rs 685.95, indicating positive market sentiment. Additionally, the stock has outperformed its sector by 0.66%, suggesting that it is performing better than its peers in the current market environment.<BR><BR>Despite the positive movement today, it is important to note that the stock has experienced a decline of 3.05% over the past week and a slight decrease of 0.88% over the past month. However, its year-to-date performance shows a robust increase of 8.24%, and it has generated a remarkable return of 40.41% over the past year, significantly outperforming the Sensex, which only increased by 4.49% in the same period.<BR><BR>The company also demonstrates high management efficiency with a return on equity (ROE) of 18.66%, and it has consistently delivered returns over the last three years. However, it faces challenges such as a high Debt to EBITDA ratio of 2.49 times, indicating a low ability to service debt, and a decline in net sales growth over the past five years. These factors could contribute to future volatility in the stock price.<BR><BR>In summary, while Aster DM Healthcare Ltd is currently experiencing a rise in stock price due to positive trading activity and strong historical performance, underlying financial challenges may pose risks that could affect its stability moving forward.

Why is Aster DM Healthcare Ltd falling/rising?

As of 09-Apr, Aster DM Healthcare Ltd's stock price is currently at 670.00, reflecting a recent upward trend and strong historical performance, despite challenges such as a high Debt to EBITDA ratio and declining net sales growth. The stock has outperformed the benchmark Sensex over the past year, indicating strong momentum.

As of 09-Apr, Aster DM Healthcare Ltd's stock price is rising, currently at 670.00, reflecting a change of 3.55 (0.53%) upward. The stock has shown a positive trend over the last two days, gaining 2.17% in that period. Additionally, it has outperformed the benchmark Sensex over the past year with a return of 36.72% compared to the Sensex's 3.77%. <BR><BR>Despite today's performance indicating a slight underperformance against its sector by -0.34%, the stock is trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a strong upward momentum in the stock's price.<BR><BR>However, it is important to note that there are some negative factors impacting the stock's overall outlook. The company has a high Debt to EBITDA ratio of 2.49 times, indicating a low ability to service its debt, and has experienced a decline in net sales growth over the past five years at an annual rate of -12.24%. Furthermore, the recent financial results show a significant drop in profit after tax, which has decreased by -85.86%. <BR><BR>Despite these challenges, the stock's recent gains and strong historical performance over the past three years, along with high management efficiency reflected in a return on equity (ROE) of 18.66%, contribute to its current rising price.

Which are the latest news on Aster DM Health.?